Caspian: Os Results from a Randomised Phase 3 Study of First-Line Durvalumab +/- Tremelimumab plus Chemotherapy in ES-SCLC

---

Reinmuth N., Paz-Ares L., Chen Y., Hotta K., Trukhin D., Statsenko G., ...More

ONCOLOGY RESEARCH AND TREATMENT, vol.43, pp.115, 2020 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 43
• Publication Date: 2020
• Journal Name: ONCOLOGY RESEARCH AND TREATMENT
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
• Page Numbers: pp.115
• Istanbul University-Cerrahpasa Affiliated: No